Lyflex 5mg/5ml oral solution
BNF presentation 1002020C0BEAAAB within chapter Musculoskeletal and Joint Diseases. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
1002020C0BEAAAB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
794
NHS spend (£)
£24,817.86
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 107 |
| December 2024 | 25 |
| November 2024 | 102 |
| October 2024 | 112 |
| August 2024 | 8 |
| July 2024 | 109 |
| May 2024 | 17 |
| July 2021 | 53 |
| June 2021 | 32 |
| December 2020 | 113 |
| November 2020 | 116 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |